Answers are grounded in this paper and cite their sources.
Review examines AI applications in reproductive medicine, revealing potential benefits and key challenges.
Artificial intelligence (AI) is increasingly being applied across multiple stages of the assisted reproductive technology (ART) pathway, with the potential to enhance clinical decision-making, optimise laboratory processes and improve workflow efficiency. This review examines the current and emerging roles of AI in reproductive medicine, including applications in ovarian stimulation, ovulation trigger timing, embryo selection, laboratory automation and patient communication. While embryo selection represents the most advanced use case, current evidence suggests that AI performs comparably to experienced embryologists, with limited demonstration of improvement in key clinical outcomes such as live birth rates. [Formula: see text]Beyond discrete applications, AI has the potential to function as an integrated system across the ART patient pathway, from initial patient engagement to post-treatment monitoring. However, significant challenges remain, including data quality and availability, model reliability and interpretability, biological complexity and variability in clinical practice. There are also important concerns regarding cost, equity and the risk that AI may be adopted as another “add-on” technology without robust evidence of meaningful benefit. [Formula: see text]Regulatory frameworks are evolving but remain fragmented, particularly for AI tools operating outside traditional clinical settings. Issues surrounding data governance, transparency and lifecycle regulation of adaptive systems further complicate implementation. In addition, the deeply personal nature of fertility care underscores the importance of maintaining trust, communication and human-centred care alongside technological advancement. [Formula: see text]Future developments are likely to involve integration of AI with genomic and multimodal data, as well as real-time physiological monitoring and adaptive treatment systems. However, progress will depend on rigorous validation, thoughtful implementation and equitable access. AI should be viewed as a tool to augment, rather than replace, clinical expertise, with its ultimate value determined by its ability to improve meaningful patient outcomes.
No takes yet. Share an insight, caveat, or question.
Robertson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: